Rivernorth Capital Management’s Aimei Health Technology Co Right AFJKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.5K Hold
172,789
﹤0.01% 505
2026
Q1
$53.2K Hold
172,789
﹤0.01% 403
2025
Q4
$64.7K Hold
172,789
﹤0.01% 367
2025
Q3
$55.3K Hold
172,789
﹤0.01% 369
2025
Q2
$41.5K Hold
172,789
﹤0.01% 273
2025
Q1
$38.9K Hold
172,789
﹤0.01% 244
2024
Q4
$20.7K Hold
172,789
﹤0.01% 292
2024
Q3
$39.7K Buy
172,789
+14,391
+9% +$3.54K ﹤0.01% 226
2024
Q2
$33.3K Hold
158,398
﹤0.01% 271
2024
Q1
$31.7K Buy
+158,398
New +$31.3K ﹤0.01% 280

Other funds holding AFJKR

Rivernorth Capital Management's AFJKR Position: Q2 2026 in Review

Rivernorth Capital Management held its Aimei Health Technology Co Right (AFJKR) position steady in Q2 2026 at 172,789 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #505.

Rivernorth Capital Management first reported a position in AFJKR in Q1 2024 and has held it in 10 quarters since. The position peaked at $64.7K in Q4 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q2 2026.

  • Rivernorth Capital Management held 172,789 shares of Aimei Health Technology Co Right worth $22.5K as of Q2 2026.
  • Rivernorth Capital Management left its Aimei Health Technology Co Right share count unchanged in Q2 2026.
  • Aimei Health Technology Co Right made up ﹤0.01% of Rivernorth Capital Management's portfolio in Q2 2026, its #505 holding.
  • Rivernorth Capital Management first reported a position in Aimei Health Technology Co Right in Q1 2024 and has held it in 10 quarters since.
  • Rivernorth Capital Management's Aimei Health Technology Co Right position peaked at $64.7K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Aimei Health Technology Co Right as of Q2 2026.

Based on Rivernorth Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.